Cargando…
Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer
BACKGROUND: Tumor-associated macrophages can promote breast cancer metastasis by secreting cytokines and growth factors. Interleukin (IL)-32θ, a newly identified IL-32 isoform, was previously shown to down-regulate various proinflammatory factors of macrophages. Here, we report the presence of IL-32...
Autores principales: | Pham, Thu-Huyen, Bak, Yesol, Kwon, Taeho, Kwon, Sae-Bom, Oh, Jae-Wook, Park, Jong-Hyung, Choi, Yang-Kyu, Hong, Jin Tae, Yoon, Do-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534939/ https://www.ncbi.nlm.nih.gov/pubmed/31126309 http://dx.doi.org/10.1186/s12964-019-0374-y |
Ejemplares similares
-
IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer
por: Bak, Yesol, et al.
Publicado: (2016) -
IL-32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU.1
por: Kim, Man Sub, et al.
Publicado: (2015) -
Inhibition of IL-13 and IL-13Rα2 Expression by IL-32θ in Human Monocytic Cells Requires PKCδ and STAT3 Association
por: Pham, Thu-Huyen, et al.
Publicado: (2019) -
Interleukin-32θ Triggers Cellular Senescence and Reduces Sensitivity to Doxorubicin-Mediated Cytotoxicity in MDA-MB-231 Cells
por: Pham, Thu-Huyen, et al.
Publicado: (2021) -
STK899704 inhibits stemness of cancer stem cells and migration via the FAK-MEK-ERK pathway in HT29 cells
por: Jang, Hui-Ju, et al.
Publicado: (2018)